. 2024 Oct 28;8:e57376. doi: 10.2196/57376

Table 3.

Vaping cessation rates among study participants (adult daily vapers in the United States) at 12 and 26 weeks after enrollment (N=73).

Outcome		Participants, n (%)
7-day PPA ^a
	12-week ITT^b	28 (38)
	26-week ITT^c	35 (48)
	12-week responder analysis^d	28 (41)
	26-week responder analysis^e	35 (51)
30-day PPA ^f
	12-week ITT^b	22 (30)
	26-week ITT^c	33 (45)
	12-week responder analysis^d	22 (32)
	26-week responder analysis^e	33 (49)
Self-reported continuous abstinence ^g
	26-week ITT^c	22 (30)
	26-week responder analysis^h	22 (33)
Abstinence from all tobacco products
	26-week ITT^c	35 (48)
	26-week responder analysis^e	35 (51)

^aPPA: point-prevalence abstinence; “In the last 7 days have you vaped/used e-cigs, even a single puff? Select one. Yes or No.”

^bITT: intention-to-treat analysis; N=73.

^cN=73.

^dN=68.

^eN=68.

^f“In the last 30 days have you vaped/used e-cigs, even a single puff? Select one. Yes or No.”

^gSelf-report of 7-day (or greater) PPA at 12 weeks, self-report of 30-day PPA at 26 weeks, and 0 vape sessions since 12 weeks.

^hResponder analysis for continuous abstinence at 26 weeks; N=67 (participants who responded to both the 12- and 26-week questionnaires).